May 22, 2025

Drug Store News features Pleio’s report revealing loneliness as a major barrier in chronic care. With 74% of patients reporting that loneliness negatively affects their physical health, the study highlights the need for peer support to improve outcomes and patient engagement.

May 22, 2025

Medication non-adherence costs the U.S. $500B annually. Pleio’s new AI, OLLIE, identifies emotional barriers through patient conversation analysis, empowering human supporters to intervene with empathy and improve outcomes.

May 7, 2025

Jen Butler, chief commercial officer at Pleio, and Mark Gregory, chief pharmacy officer at Pleio, sat down for an interview with Pharmacy Times at Asembia’s AXS25 Summit. They discussed the critical role of emotional support in specialty pharmacy. Drawing on insights from a recent report, Butler and Gregory highlighted the importance of addressing patient barriers in improving medication adherence.

WE PUT PRIVACY FIRST. GOODSTART® IS A FULLY TESTED, HIGHLY RELIABLE, TCPA, SOC 2 TYPE 2 CERTIFIED, AND HIPAA COMPLIANT MEDICATION SUPPORT PROGRAM.

Patient data is strictly used to support patients to take medications as prescribed by their healthcare professional.

CONTACT   |   PRIVACY   |   SUPPLIER CONDUCT   |  CAREERS



© 2025 Pleio, Inc All rights reserved.